Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)

NCT01077817 · clinicaltrials.gov ↗

COMPLETED

Status

684815

Enrollment

INDUSTRY

Sponsor class

Conditions

Esophageal Cancer
Squamous Cell Carcinoma
Adenocarcinoma

Interventions

DRUG: Alendronate
DRUG: Etidronate
DRUG: Ibandronate
DRUG: Risedronate
DRUG: Raloxifene

Sponsor

Organon and Co

Collaborators

[object Object]